(Q34006304)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Immunological responses to oxidized LDL (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

S Hörkkö

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P X Shaw

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M K Chang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

G Silverman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

W Palinski

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J L Witztum

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

Free Radical Biology and Medicine

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

1771-1779

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

Atherosclerotic plaque rupture--pathologic basis of plaque stability and instability

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Cell-mediated immunity in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Are immunological mechanisms relevant for the development of atherosclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Accumulation of plasma cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Autoimmunity and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Low density lipoprotein undergoes oxidative modification in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins)

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Lipoprotein modification and atherosclerosis in aging

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Is oxidized low‐density lipoprotein present in vivo?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Cardiolipin is a normal component of human plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Functional diversity of helper T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

IFN-gamma potentiates atherosclerosis in ApoE knock-out mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Protective Role of Interleukin-10 in Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Interleukin-10 blocks atherosclerotic events in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900333-6

7 January 2021

10.1016/S0891-5849(00)00333-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10946219%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference